Bioteknisk forskning och utveckling SNI 72101
I branschen Bioteknisk forskning och utveckling finns 353 aktiebolag med årsredovisningsdata. Visar plats 201–300, sorterade på omsättning.
353
aktiebolag
542.8 M
kr i samlad omsättning
562
anställda
-3.6%
median rörelsemarginal
Bolag — plats 201–300 efter omsättning
| # | Bolag | Omsättning | Rörelseresultat | Marginal | Anställda |
|---|---|---|---|---|---|
| 201 | MNJ Consulting AB | 4 | -18.8 k | -469325.0% | 0 |
| 202 | NeoTargets AB | 4 | -2.4 M | -705.3% | 1 |
| 203 | Nordlight Medical AB | 2 | -13.5 k | -674550.0% | — |
| 204 | waveseven AB | 1 | -369.0 k | -36901500.0% | — |
| 205 | Spixia Biotechnology AB | 0 | -104.8 k | — | — |
| 206 | WOODHEADS AB | 0 | -47.4 k | — | — |
| 207 | Future Fields AB | 0 | -495 | — | — |
| 208 | EVITRAPROTEOMA AB | 0 | 265.5 k | 92.1% | — |
| 209 | Akloma BioScience Aktiebolag | 0 | -1.1 M | — | 0 |
| 210 | Microtus AB | 0 | -42.3 k | — | — |
| 211 | Raise-In AB | 0 | -10.3 k | — | 0 |
| 212 | Landegren Gene Technology AB | 0 | -634.0 k | — | — |
| 213 | Novoaim AB | 0 | -20.0 k | — | — |
| 214 | The Barclay Consultancy AB | 0 | -306.9 k | — | — |
| 215 | Diagnos & Vård HP AB | 0 | 84.2 k | 29.3% | — |
| 216 | Qgut AB | 0 | -199.4 k | — | 0 |
| 217 | BioAll AB | 0 | -17.7 k | — | — |
| 218 | ThunderWave Consulting AB | 0 | -240.6 k | -190.4% | 1 |
| 219 | MixIA AB | 0 | -7.5 k | — | — |
| 220 | Biomedrex AB | 0 | 1.2 M | 43.9% | 3 |
| 221 | Holy Diver Consulting AB | 0 | -55.7 k | — | 1 |
| 222 | ALLPEP AB | 0 | -10.2 k | — | 0 |
| 223 | Innoscentia AB | 0 | -3.3 M | -177.6% | 5 |
| 224 | Uppsala Therapeutics AB | 0 | -97.6 k | — | — |
| 225 | Instagraft AB | 0 | -35.1 k | — | — |
| 226 | Alertix Veterinary Diagnostics AB | 0 | -1.2 M | -157.4% | 0 |
| 227 | Doloradix AB | 0 | -2.1 M | -66581.2% | 1 |
| 228 | Simplexia AB | 0 | -4.2 M | -384.8% | 2 |
| 229 | Nvigorea AB | 0 | -389.4 k | — | — |
| 230 | pSk earth adaption AB | 0 | -15.5 k | — | 1 |
| 231 | POW Consulting AB | 0 | -3.0 k | — | — |
| 232 | AB MAvatar | 0 | -43.3 M | -626.9% | 22 |
| 233 | Eskerway AB | 0 | -5.7 k | — | 0 |
| 234 | Omnia Biotech AB | 0 | -26.1 k | — | 0 |
| 235 | Active Scent AB | 0 | -378.4 k | -9505.1% | — |
| 236 | Cirkulär AB | 0 | -4.4 M | -167.0% | 5 |
| 237 | Szafran Biopsy AB | 0 | -87.2 k | — | — |
| 238 | BioTab AB | 0 | -8.7 k | -3167.8% | 0 |
| 239 | TTA TopCo AB | 0 | 0 | — | — |
| 240 | BeMa BioConsulting AB | 0 | -36.6 k | — | — |
| 241 | Vitroprobe Analytics AB | 0 | -1.2 M | -139.4% | 2 |
| 242 | Nordic SARS Response AB | 0 | -2.0 k | — | — |
| 243 | Afiyet AB | 0 | -515.9 k | -245.7% | 1 |
| 244 | Masker Med Tech AB | 0 | 7.0 k | 8.9% | — |
| 245 | NBTech AB | 0 | -567.0 k | -36.3% | 2 |
| 246 | Circular Biotech AB | 0 | -98.4 k | — | — |
| 247 | Swedish Neurotherapeutics AB | 0 | -5.9 k | — | 0 |
| 248 | Virenc Holding AB | 0 | 21.5 k | 95.6% | — |
| 249 | Tribune Therapeutics AB | 0 | -23.1 M | -14851.2% | 1 |
| 250 | Moroxite AB | 0 | -11.7 M | -484.0% | 4 |
| 251 | Moroxite I AB | 0 | -126.8 k | — | — |
| 252 | TTA-LG HoldCo AB | 0 | -10.4 k | — | — |
| 253 | BioDevelopment 101 AB | 0 | -11.0 k | — | — |
| 254 | Oxiant Discovery AB | 0 | 888.0 k | 25.9% | — |
| 255 | Theralia AB | 0 | 8.8 k | 7.5% | — |
| 256 | Peckiiless AB | 0 | -33.9 k | -338.7% | — |
| 257 | TTA Covid SPV AB | 0 | 19.4 M | 99.8% | — |
| 258 | Morsing Consulting inWest AB | 0 | -929 | -1.6% | 1 |
| 259 | Moleculent AB | 0 | -29.1 M | — | 16 |
| 260 | NaturaLens AB | 0 | -16.1 k | -17.5% | — |
| 261 | 3N Bio AB | 0 | -28.2 k | -433.7% | — |
| 262 | AA17 Invest AB | 0 | -293.3 k | — | 0 |
| 263 | Prolevi Bio AB | 0 | -1.2 M | -83.9% | — |
| 264 | Zero Cycles AB | 0 | -1.6 k | — | 0 |
| 265 | AAstrid Pharma AB | 0 | -44.6 k | — | — |
| 266 | Horizon Bioinnovation AB | 0 | -45.5 k | -28.9% | 1 |
| 267 | Skåne BnB AB | 0 | 0 | — | 0 |
| 268 | Normoxia Sverige AB | 0 | -16.7 k | — | — |
| 269 | Xerapeutics AB | 0 | -2.9 M | — | 1 |
| 270 | NYZU AB | 0 | -168.6 k | — | — |
| 271 | Fenode Therapeutics AB | 0 | -1.2 k | — | 0 |
| 272 | UGLL Science AB | 0 | -2.8 M | — | 1 |
| 273 | MetSef AB | 0 | 0 | — | — |
| 274 | Simple Domain AB | 0 | -49.2 k | — | — |
| 275 | Silversand Consulting AB | 0 | -15.7 k | — | — |
| 276 | Samplimy Medical AB | 0 | 94.3 k | 17.2% | 0 |
| 277 | QuantiMic AB | 0 | 0 | — | 0 |
| 278 | Line Genomics AB | 0 | -2.8 k | — | — |
| 279 | APOEasy AB | 0 | 0 | — | — |
| 280 | Emulsi Biotech AB | 0 | -118.5 k | -42.5% | 1 |
| 281 | Agteria Biotech AB | 0 | -7.6 M | -112.8% | 2 |
| 282 | Sanglife Solutions AB | 0 | -66.6 k | — | — |
| 283 | Auweai AB | 0 | -11.1 k | — | — |
| 284 | Cutis Skin Health Sweden AB | 0 | -72.8 k | — | — |
| 285 | Secretech Sweden AB | 0 | -1.0 M | — | 1 |
| 286 | Virenc AB | 0 | -29.7 k | -99.3% | — |
| 287 | Cubase Bio AB | 0 | -8.7 M | -2315.2% | 6 |
| 288 | Haga Bioscience AB | 0 | -4.2 M | -3559.9% | 5 |
| 289 | Wearapore AB | 0 | -625 | — | 0 |
| 290 | Caneon AB | 0 | -2.2 M | — | — |
| 291 | Space Greens AB | 0 | -4.5 k | — | 0 |
| 292 | Nordic MicrobTech AB | 0 | -373 | — | 0 |
| 293 | Nordic Kinetics AB | 0 | -379.9 k | -114.9% | 1 |
| 294 | Core-Oli-T AB | 0 | -50.8 k | — | — |
| 295 | AdvantCells Nordic AB | 0 | -411.8 k | -11839.3% | 0 |
| 296 | BIOLYSION AB | 0 | -385.2 k | — | 1 |
| 297 | Re:Mine AB | 0 | -13.3 k | -25.5% | — |
| 298 | GenomeVault AB | 0 | -126.2 k | — | 1 |
| 299 | Intellaif AB | 0 | -2.5 k | — | — |
| 300 | Xkout Bioscience AB | -1 | -9.0 k | — | — |
201–300 av 353 bolag · sida 3 av 4